TP53 and colorectal carcinoma: Although the report by Do et al. found that metformin enhanced apoptosis in the wild-type p53 HCT116 cells by increasing the p53 expression and miR-34a which downregulates Sirt1 expression and its subsequent downstream effectors, the role of Sirt1 in cancer particularly CRC is still debatable and requires further validation.